BLOG / 🇮🇳 India / index intelligence · · daily

BSE Sensex 30 Stocks Regulatory Filings — November 04, 2026

India BSE SENSEX 30

By Gunpowder Editorial ·

2 high priority 18 medium priority 20 total filings analysed

Executive Summary

Across the 20 filings for the BSE SENSEX 30 stream dated 4 November 2026, the dominant theme is a sharp divergence between volume-led demand strength and margin pressure from input costs and currency.

The clearest quantitative signal is IndiGo's Q2 FY27 call: total income rose 24% YoY to ₹243 billion and PRASK grew 31%, yet fuel CASK jumped 69% and the net loss narrowed only to ₹19 billion from ₹26 billion, with full-year CASK guidance now pointing to high-single to early-double-digit increases. Hindustan Unilever shows the same squeeze at the gross-margin line, with gross margin down roughly 400 bps and EBITDA margin down 140 bps to 22.6% even as USG hit 15%, its strongest in 14 quarters. Sun Pharma reported sales up 11.8% YoY but US sales down 8.2% on lenalidomide erosion and a slowing Ilumya, with the Organon deal still on track for Q4 FY27 closing. Governance and balance-sheet items were benign: Bajaj Finance's EGM approvals passed with over 99% in favour, Mahindra & Mahindra's AAA rating was reaffirmed with gearing of 0.09x, and Reliance's 'A-' rating was reaffirmed as Stable. The bulk of the remaining filings are administrative (RTA relocations, investor-conference notices, newspaper clippings) and carry no financial impact.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Company update · Corporate governance

Tracking the trend? Catch up on the prior BSE Sensex 30 Stocks Regulatory Filings digest from October 28, 2026.

Investment Signals (9)

  • InterGlobe Aviation (IndiGo) (MIXED)
    ▲

    Total income up 24% YoY to ₹243bn, PRASK up 31%, and Q3 PRASK guided above 25% YoY on October trends; offset by fuel CASK up 69% and full-year CASK ex-fuel guided to rise high-single to early-double digits; end of widebody damp-lease from 1 Nov 2026

  • Sept-quarter USG of 15% and UVG of 7% were the strongest in 14 quarters, but PAT was flat YoY reported (ex-exceptional +9% to ₹2,795 crore) and EBITDA margin fell 140 bps to 22.6%; management reiterated a 22–24% medium-term EBITDA margin band

  • Q2 FY27 sales up 11.8% YoY to ₹16,100 mn and India formulations up 17.3%, but US sales down 8.2% to $455mn and reported PAT of ₹19,885 mn vs adjusted ₹31,620 mn; Organon acquisition on track to close in Q4 FY27

  • CARE reaffirmed AAA/Stable with gearing of 0.09x and cash plus liquid investments of ₹39,364 crore; consolidated TOI up ~26% to ₹176,440 crore in FY26 but PBILDT margin eased to 13.17% from 13.34%

  • ▲

    EGM approved preferential warrant issuance to promoter Bajaj Finserv with 99.59% e-votes in favour and QIP authority with 99.97% in favour, signalling strong shareholder backing for the capital raise

  • S&P reaffirmed 'A-' rating with Stable outlook on USD fixed-rate notes, confirming no rating pressure on the group's external debt

  • ▲

    Rs. 1.07 lakh DoT penalty over CAF audit non-compliance, not contested; financial impact immaterial but flags subscriber-verification compliance scrutiny

  • Axis Bank ↓ (NEUTRAL)
    ▲

    RBI approved re-appointment of Whole-Time Director Munish Sharda for three years from 27 Feb 2027; removes one of two open conditions, shareholder approval still pending

  • TCS (NEUTRAL)
    ▲

    Enterprise AI study finds 84% of leaders see productivity as AI's top value, but only 10% allow autonomous AI decision-making and only 9% report secure multi-app orchestration, a tempering signal on near-term AI services demand

Risk Flags (8)

  • Fuel CASK up 69% YoY and rupee depreciation kept the Q2 net loss at ₹19bn despite 24% income growth; FY27 CASK ex-fuel guided to rise high-single to early-double digits, leaving margin recovery dependent on yields

  • Gross margin contracted ~400 bps YoY with management acknowledging a lag between input-cost inflation and pricing; ~260 bps offset came from overheads and A&P leverage, which is not repeatable indefinitely

  • US sales fell 8.2% YoY to $455mn on lenalidomide erosion with Ilumya growth slowing materially; Q2 R&D of ₹7,784 mn was below intended levels, and EBITDA margin of 29.3% was down YoY

  • ▼

    Ophthalmic production halt at the Assam plant following voluntary recall of 11 products, with further acquisition-related exceptional costs flagged until Organon closing

  • Farm equipment profitability weakened by losses in certain international operations, prompting exits or restructuring, and PBILDT margin slipped to 13.17% from 13.34%

  • DoT penalty for subscriber-verification (CAF) violations, with the company choosing not to contest; repeated audit findings could escalate compliance costs across licence areas

  • Reported PAT flat YoY vs +9% pre-exceptional growth because of a prior-year one-off tax gain of ₹273 crore, making headline comparisons look weaker than underlying operations

  • TCS/AI Governance Gap [LOW RISK]
    ▼

    Only 7% of respondents have provider-switching continuity plans and 10% permit autonomous AI execution, implying slower enterprise AI monetisation than headline adoption suggests

Opportunities (7)

  • Management guided Q3 FY27 capacity up in early single digits and PRASK up more than 25% YoY on October trends, with flat load factor in a seasonally stronger quarter; a fuel-price stabilisation would convert this top-line momentum into earnings

  • 15% USG and 7% UVG with quick commerce above 50% USG and 3.5x–6x share multiples versus nearest competitors across categories; reaffirmed 22–24% EBITDA margin band implies margin repair as input costs stabilise

  • Organon acquisition expected to close in Q4 FY27 and India formulations grew 17.3% to ₹55,523 mn; successful integration and R&D catch-up in H2 could support a re-rating once US erosion is absorbed

  • Completed 58.97% stake in SML Mahindra in FY26, lifting >3.5T CV share to ~6%, with ten ICE SUVs and six BEVs planned by 2031; fortress balance sheet (0.09x gearing) funds product cycle

  • ◆

    With EGM approvals in hand for the promoter warrant issue and QIP, the company has ready headroom to fund growth; execution timing is the key catalyst to monitor

  • Stable 'A-' rating reaffirmed on dollar notes listed in Luxembourg and Singapore, supporting continued access to offshore funding at current spreads

  • TCS/Enterprise AI Services (OPPORTUNITY)
    ◆

    84% of executives rank productivity as AI's top value and security/governance now leads deployment decisions, creating demand for governance and orchestration services where TCS can differentiate

Sector Themes (6)

  • Input-Cost Squeeze Across Consumer and Transport (SECTOR)
    ◆

    IndiGo (fuel CASK +69%) and HUL (gross margin −400 bps) both report revenue or volume strength offset by cost inflation and pricing lag, pointing to a common pass-through challenge for FMCG and aviation

  • Volume-Led Growth vs Margin Recovery (SECTOR)
    ◆

    HUL's 7% UVG and IndiGo's flat-to-stronger load factors show demand is intact, while margin recovery depends on pricing and cost relief, so the investment case is running through operating leverage rather than volume alone

  • Pharma US Erosion Offset by India Strength (SECTOR)
    ◆

    Sun Pharma's US sales −8.2% against India formulations +17.3% illustrates a domestic-led growth mix in large-cap pharma while specialty US franchises face generic and lifecycle erosion

  • Compliance and Shareholder-Governance Hygiene (SECTOR)
    ◆

    Bharti Airtel's DoT CAF penalty, Bajaj Finance's EGM approvals with 99%+ support, and HUL's non-executive remuneration postal ballot show routine regulatory process activity, with compliance-related fines remaining immaterial

  • Credit Ratings Stable Across Conglomerates (SECTOR)
    ◆

    M&M (AAA/Stable, gearing 0.09x) and Reliance (A-/Stable) both had ratings reaffirmed with no downgrade pressure, supporting a stable credit backdrop for large-cap corporates

  • Administrative RTA Relocation to Kokapet, Hyderabad (SECTOR)
    ◆

    UltraTech, Bharti Airtel and L&T all flagged KFin Technologies relocation effective 1 December 2026, a shared operational change with no financial impact

Watch List (8)

  • Watch whether PRASK growth above 25% YoY and flat load factor hold through the December quarter, and whether fuel CASK pressure eases; management's full-year CASK ex-fuel guidance is the key number to track [Q3 FY27 results, approx. Jan 2027]

  • Track whether gross-margin pressure eases and whether EBITDA margin recovers toward the 22–24% band in the December quarter; the Home Care A&P cut of ~₹250 crore is a factor to watch [Q3 FY27 results]

  • Monitor closing conditions and timing of the Organon acquisition (Q4 FY27), the Assam plant halt and recall impact on US/India sales, and H2 R&D catch-up [Q4 FY27]

  • Non-Executive Director remuneration cap of ₹15 crore or 1% of net profits (lower of the two) for FY27–FY31; e-voting runs 18 Nov to 17 Dec 2026, results by 19 Dec 2026 [17 Dec 2026]

  • Watch timing and pricing of the QIP and promoter preferential warrant allotment following the 2 Nov 2026 EGM approvals [Post-EGM, no date disclosed]

  • Shareholder approval of Munish Sharda's re-appointment as Whole-Time Director, the outstanding condition after RBI approval dated 4 Nov 2026; term from 27 Feb 2027 [Pending]

  • Investor Conference Circuit
    👁

    JM Financial (16 Nov), CITIC CLSA India Forum (16 Nov), and Morgan Stanley Asia Pacific Summit (18–19 Nov) attendance by ITC, HCL Technologies, and Adani Ports; watch for any guidance commentary in one-on-one meetings [16–19 Nov 2026]

  • Monitor whether the CAF audit findings lead to further DoT notices or licence-level scrutiny beyond the ₹1.07 lakh penalty [Ongoing]

Filing Analyses (20)
Power Grid Corporation of India Limited Analyst/Investor Meet neutral materiality 2/10

04-11-2026

Power Grid Corporation of India Limited disclosed under Regulation 30 of the SEBI LODR Regulations that its Analysts' & Institutional Investors' Meet, held on 03 November 2026 at 15:00 Hrs IST in Mumbai, has been recorded and the audio and video links have been shared with the exchanges. The senior management team discussed the company's business and outlook following the declaration of financial results for the second quarter and half year ended 30 September 2026. The filing itself contains no quantitative financial figures, guidance, or specific business metrics.

  • · Meet held on Tuesday, 03 November 2026 at 15:00 Hrs IST at Mumbai
  • · Meet followed the declaration of Q2 and H1 FY27 results (quarter and half year ended 30 September 2026)
  • · Audio and video recordings of the meet are available via links provided in the filing
  • · NSE symbol POWERGRID; BSE scrip code 532898; ISIN INE752E01010
ITC Limited Company Update neutral materiality 2/10

04-11-2026

ITC Limited has disclosed under Regulation 30 of the SEBI LODR Regulations that its representatives will attend two investor forums: the 29th CITIC CLSA India Forum 2026 in Mumbai on 16 November 2026 (organised by CLSA India Private Limited) and Morgan Stanley's 25th Annual Asia Pacific Summit in Singapore on 18-19 November 2026, with physical one-to-one meetings with investors. The filing contains no financial results, guidance, or quantitative performance data.

  • · CLSA India Forum event on 16 November 2026 in Mumbai is physical attendance at the 29th edition
  • · Morgan Stanley 25th Annual Asia Pacific Summit on 18-19 November 2026 in Singapore includes physical one-to-one investor meetings
  • · Filing copied to the US SEC Division of Corporate Finance and the Luxembourg Stock Exchange, indicating ITC's listing/reporting footprint beyond India
UltraTech Cement Limited Market Update neutral materiality 1/10

04-11-2026

UltraTech Cement Limited has informed stock exchanges that its Registrar and Share Transfer Agent, KFin Technologies Limited, will relocate its corporate office and shareholder operations centre to Kokapet, Hyderabad, effective 1 December 2026. Shareholders are advised to direct all share-related correspondence to the new address from that date. The filing is administrative and carries no financial or operational impact on UltraTech.

  • · Effective date of RTA office relocation: 1 December 2026
  • · New RTA shareholder correspondence contact: [email protected], toll-free 1800 309 4001, WhatsApp (91) 910 009 4099
  • · Filing was disclosed to BSE, NSE and the Luxembourg Stock Exchange (ADR/GDR listing)
Bajaj Finance Limited Corporate Governance neutral materiality 6/10

04-11-2026

Bajaj Finance Limited held an Extraordinary General Meeting (EGM) on 2 November 2026 via VC/OAVM, where shareholders passed two special resolutions: (1) issuance of warrants on a preferential basis to promoter and holding company Bajaj Finserv Limited, approved with 99.5921% of e-votes in favour, and (2) issuance of securities under a Qualified Institutions Placement (QIP), approved with 99.9734% of e-votes in favour. The Scrutinizer's Report dated 3 November 2026 confirmed the voting process was conducted fairly and transparently.

  • · Item 1 (preferential warrants to promoter Bajaj Finserv Limited) received 21,765,753 votes against, versus 5,313,667,577 in favour, with 178,545,269 abstained votes in the consolidated Scrutinizer's Report
  • · Item 1 was also approved on a promoter-interested basis as the warrant allottee is the promoter, though the filing marks promoter interest as 'No'
  • · Remote e-voting ran from 29 October 2026 to 1 November 2026; votes were unblocked on 2 November 2026 in the presence of two independent witnesses
  • · The EGM was held 12:45 PM to 1:17 PM IST on 2 November 2026, with 635 public and 28 promoter-group attendees via VC/OAVM
Bharti Airtel Limited Company Update negative materiality 2/10

04-11-2026

Bharti Airtel received a notice from the Department of Telecommunications (DoT), Maharashtra LSA, on November 3, 2026, imposing a penalty of Rs. 1,07,000 for alleged violation of subscriber verification (CAF) norms identified in a DoT Customer Application Form Audit for August 2026. The company has opted not to contest and will pay the penalty, so the maximum financial impact is limited to this amount.

  • · Notice relates to the CAF Audit conducted by DoT for August 2026, alleging violation of subscriber verification terms under the License Agreement
  • · Company decided not to contest the penalty and will pay it
  • · Filed under Regulation 30 of SEBI Listing Regulations, disclosed to NSE and BSE
Bharti Airtel Limited Company Update neutral materiality 1/10

04-11-2026

Bharti Airtel Limited has informed the NSE and BSE that its Registrar and Share Transfer Agent, KFin Technologies Limited, will shift its corporate office effective December 1, 2026, from Rajapushpa West Avenue, Nanakramguda, Gachibowli to Selenium Tower B, Kokapet, Hyderabad. The change is administrative only, and the RTA's registered office remains unchanged.

  • · Effective date of the RTA office relocation is December 1, 2026
  • · Registered office address of the RTA is unchanged
InterGlobe Aviation Limited Company Update mixed materiality 8/10

04-11-2026

IndiGo (InterGlobe Aviation) filed the transcript of its Q2 FY2027 earnings call held October 29, 2026. The company reported a net loss of ₹19 billion for the quarter (vs. a ₹26 billion loss a year earlier), with total income up 24% YoY to ₹243 billion and PRASK up 31%, yet heavy fuel costs (fuel CASK up 69%) and rupee depreciation kept profitability under pressure. Management also announced the end of its widebody damp-lease operations from November 1, 2026.

  • · Management expects Q3 FY27 capacity to grow in the early single digits YoY and PRASK to grow more than 25% YoY based on October trends
  • · Q3 load factor expected to be flat YoY, despite the seasonally stronger quarter
  • · Full-year FY27 guidance: capacity growth in early single digits; CASK ex fuel ex forex MTM to rise high single digits to early double digits
  • · Management expects widebody exit to be accretive to spreads (RASK minus CASK); exact figures not disclosed
  • · Analyst questions on the sequential decline in fuel CASK and the impact of new Navi Mumbai airport flights on profitability were raised in the Q&A; transcript of Q&A to be uploaded subsequently
  • · Dar es Salaam daily direct service from Mumbai began in November 2026, expanding Africa presence
Axis Bank Limited Market Notice neutral materiality 3/10

04-11-2026

Axis Bank Limited has informed the NSE and BSE under Regulation 30 of the SEBI Listing Regulations that the Reserve Bank of India approved, via letter dated November 4, 2026, the re-appointment of Munish Sharda as Whole-Time Director (designated Executive Director) for a further three years, from February 27, 2027 to February 26, 2030. The approval fulfils one of the two conditions noted in the Bank's June 29, 2026 intimation; shareholder approval remains outstanding.

  • · RBI approval letter reference: CO.HGG.DOR.No.S6304/08.86.001/2026-27 dated November 4, 2026
  • · Re-appointment term runs February 27, 2027 to February 26, 2030 (both days inclusive), subject to shareholder approval still pending
  • · Filing is a follow-up to the Bank's June 29, 2026 intimation (ref. AXIS/CO/CS/208/2026-27)
Larsen & Toubro Limited Company Update neutral materiality 1/10

05-11-2026

Larsen & Toubro Limited has notified BSE and NSE that its Registrar and Share Transfer Agent, KFin Technologies Limited, is relocating its corporate office to a new address in Kokapet, Ranga Reddy District, Telangana, effective December 01, 2026. The filing is an administrative disclosure under SEBI LODR Regulations, 2015, and contains no financial results or performance data.

  • · RTA office relocation effective December 01, 2026
  • · New RTA address: 6, 23, 24, 25th Floor, South Tower, Rajapushpa West Avenue, Survey No. 115, Kokapet, Ranga Reddy District, Telangana - 500075
  • · Filing made under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; BSE stock code 500510 and NSE symbol LT
Adani Ports and Special Economic Zone Limited Company Update neutral materiality 2/10

05-11-2026

Adani Ports and Special Economic Zone Limited has notified the exchanges that it will interact with investors and analysts at the JM Financials India Conference on November 16, 2026, in Mumbai, through one-on-one and group meetings. The presentation for the meeting has been uploaded to the company's website, and the schedule is subject to change.

  • · Investor/analyst interaction scheduled for 16 November 2026 at JM Financials India Conference, Mumbai, format: physical, one-on-one and group meetings
  • · Meeting presentation uploaded to www.adaniports.com
  • · Schedule subject to change due to exigencies on the part of investors or the company
  • · Disclosure made under Regulation 30 of SEBI (LODR) Regulations, 2015; BSE scrip code 532921, NSE symbol ADANIPORTS
Sun Pharmaceutical Industries Limited Analyst/Investor Meet mixed materiality 8/10

04-11-2026

Sun Pharmaceutical Industries held its Q2 FY27 earnings call on October 30, 2026, reporting consolidated sales of INR1,61,000 million (up 11.8% YoY), gross margin of 80.8%, EBITDA of INR47,439 million (up 4.8% YoY, margin 29.3%, lower YoY partly due to a lenalidomide benefit in Q2 FY26), and reported PAT of INR19,885 million versus adjusted PAT of INR31,620 million with EPS of INR8.3. US sales declined 8.2% to USD455 million on lenalidomide erosion, with Ilumya slowing materially, while India formulations grew 17.3% to INR55,523 million and emerging markets grew 7.6% to USD350 million. The Organon acquisition is on track to close in Q4 FY27, and an ophthalmic production halt at the Assam plant following voluntary recalls of 11 products was discussed.

  • · Management said Ilumya US growth slowed due to a mix of market factors and execution issues, with interventions in place and expected return to typical growth 'over the next few quarters'
  • · Q2 FY27 R&D spend of INR7,784 million was below intended levels; management expects H2 catch-up, with R&D guidance of 6% to 7% referenced by an analyst but not reconfirmed in numeric terms by management
  • · Organon acquisition expected to close in Q4 FY27 and is subject to remaining customary closing conditions; further acquisition-related exceptional costs are expected until closing
  • · Management stated FY27 guidance remains as given at the beginning of the year, with no updated numeric guidance provided
  • · Ophthalmic products recall: 11 products voluntarily recalled and manufacturing temporarily ceased at the Assam plant; management declined to comment on media reports of a regulator directive
  • · US government agreement extends MFN pricing to state Medicaid programs, delays Section 232 tariffs on innovative products by over 2 years, and exempts Sun from GLOBE and GUARD Medicare models
  • · India volume growth was 6.7% versus IPM growth of 1.8%; management said roughly 50% to 60% of India growth came from volume plus new products, with the rest from pricing
  • · Constant-currency emerging markets growth was 7.4%; Rest of World growth was lower and management did not guide to specific growth numbers
  • · Gross margin benefited from better product mix and favorable currency tailwinds; EBITDA margin declined YoY partly due to lenalidomide sales in Q2 FY26
Hindustan Unilever Limited Market Notice positive materiality 4/10

04-11-2026

Hindustan Unilever Limited filed an investor presentation under Regulation 30 of the SEBI LODR Regulations, to be made at an upcoming analyst/institutional investor meet. The deck positions India FMCG as a large runway for growth and highlights underlying sales growth accelerating across recent quarters, with quick commerce showing over 50% USG and open-format and health & beauty store initiatives reporting strong per-store growth. The filing contains no reported financial results, so the deck's figures are management's operating metrics rather than audited statements.

  • · Underlying volume growth is cited alongside underlying sales growth as a driver of the volume-led revenue story, with the quarterly USG chart spanning SQ'25 to SQ'26.
  • · Management frames the Indian market as having a 60X+ relative consumption gap versus Indonesia-type penetration in laundry soaps, indicating long-term headroom claims that are not quantified as HUL-specific targets.
  • · Market leadership claims include 3.5x to 6x nearest-competitor share multiples across hair care, skin care, skin cleansing, laundry, dishwash and lifestyle/nutrition categories (Nielsen MAT Sep'26).
  • · Management cites 'Employer of Choice' (#1) based on an InsideIIM brand perception study of top Indian B-schools in 2025.
  • · Advantage Survey rank #2 for quick commerce partners Blinkit and Swiggy Instamart is cited as a performance benchmark.
  • · The deck identifies eight multi-year strategic bets, including scaling home care liquids and building masstige beauty and superfood nutrition positions.
Hindustan Unilever Limited Analyst/Investor Meet mixed materiality 7/10

04-11-2026

Hindustan Unilever reported a September 2026 quarter with Turnover of Rs. 18,071 crore, 15% Underlying Sales Growth (USG) and 7% Underlying Volume Growth (UVG), its strongest USG in 14 quarters. PAT before exceptional items grew 9% to Rs. 2,795 crore, but reported PAT was flat year-on-year because of a one-off tax-related gain of Rs. 273 crore in the base period. Gross margin contracted roughly 400 basis points and EBITDA margin fell 140 basis points to 22.6%, with management attributing the gap to a lag between input-cost inflation and pricing; Home Care EBIT growth also moderated, while Health & Wellbeing and Oral Care were subdued.

  • · Gross margin contracted roughly 400 basis points YoY while EBITDA margin fell 140 basis points, with management citing about 260 basis points of offset from overheads and A&P operating leverage
  • · Home Care A&P was cut by about Rs. 250 crore in the quarter while spend rose in other categories
  • · Management reiterated a medium-term EBITDA margin range of 22% to 24%, expanded by 50 bps on either side from prior guidance
  • · Interim dividend of Rs. 19 per share declared for FY27
  • · Health & Wellbeing (OZiva) and Oral Care grew subdued; Oral Care at low-single digits
  • · Mass tea was softer due to inflation-driven pricing; Lifebuoy performance remains a weak point
  • · Management expects roughly 10% A&P savings from non-working media, AI tools and buying efficiency
Mahindra & Mahindra Limited Company Update mixed materiality 5/10

05-11-2026

CARE Ratings reaffirmed M&M's long-term and short-term bank facilities at 'CARE AAA; Stable' and 'CARE A1+' on November 4, 2026, covering ₹2,173.17 crore in total facilities (₹10.00 crore, ₹24.11 crore and ₹2,139.06 crore). Consolidated total operating income (excluding MMFSL) rose ~26% to ₹176,440 crore in FY26 from ₹140,579 crore in FY25, while PBILDT margin eased slightly to 13.17% from 13.34%, reflecting weaker farm equipment profitability from certain international operations. Liquidity remains strong with cash and liquid investments of ₹39,364 crore and overall gearing of 0.09x.

  • · Farm equipment segment profitability weakened due to losses in certain international operations; management is exiting or restructuring loss-making overseas businesses
  • · M&M completed the acquisition of a 58.97% stake in SML Mahindra Limited in FY26, lifting its >3.5T CV market share to ~6%
  • · Company plans to launch ten ICE SUVs (including one mid-cycle enhancement) and six BEVs by 2031
  • · Rating sensitivities: negative triggers include gearing above 1.0x from debt-funded capex or acquisitions, and sustained deterioration in core volumes or profitability; no positive triggers are applicable
  • · No Credit Rating exists for the company's Non-Convertible Debentures, so Regulation 30 and 55 disclosure requirements for those instruments do not apply
  • · Company holds a 37% renewable electricity share and targets 47% Scope 1 and 2 emission intensity reduction by 2033 versus the 2018 baseline
Hindustan Unilever Limited Market Update neutral materiality 4/10

04-11-2026

Hindustan Unilever Limited's Board has proposed seeking shareholder approval via Postal Ballot to revise the annual aggregate remuneration limit for Non-Executive Directors for five years (April 1, 2026 to March 31, 2031). The proposed cap is ₹15 crore per annum or 1% of Net Profits, whichever is lower. The voting process is scheduled to conclude on December 17, 2026, with results declared by December 19, 2026.

  • · Remuneration revision covers the period April 1, 2026 to March 31, 2031 (five years)
  • · Cut-off date for member voting eligibility is November 6, 2026
  • · Electronic voting runs from November 18, 2026 to December 17, 2026
  • · Board resolution authorizing the postal ballot process was dated October 28, 2026
  • · Notice dispatch to members to be completed by November 13, 2026; newspaper advertisement on November 16, 2026
  • · Minutes signing deadline by the Chairman is January 15, 2027
Kotak Mahindra Bank Limited Market Update neutral materiality 2/10

04-11-2026

Kotak Mahindra Bank Limited filed a newspaper clipping, published in Business Standard on November 4, 2026, announcing a special window from February 5, 2026 to February 4, 2027 for transfer and dematerialisation of physical securities purchased or sold prior to April 1, 2019, in line with SEBI Circular dated January 30, 2026. Transfer deeds are to be lodged with the Registrar and Transfer Agent, KFin Technologies Limited, in Hyderabad. The filing itself contains no new financial results or deal disclosures.

  • · Special window open from February 5, 2026 to February 4, 2027
  • · Applies to physical securities bought or sold before April 1, 2019
  • · Filing is a regulatory compliance disclosure, not a financial result
State Bank of India Market Update materiality 5/10

04-11-2026

Reliance Industries Limited Company Update neutral materiality 3/10

05-11-2026

Reliance Industries Limited disclosed that S&P Global Ratings reaffirmed its 'A–' credit rating with a 'Stable' outlook on the company's Senior Unsecured US$ Denominated Fixed Rate Notes, per a press release dated November 3, 2026. The filing is an informational re-affirmation with no change in rating or outlook, and no new financial amounts or operating metrics are disclosed.

  • · Rating reaffirmed at 'A–' with 'Stable' outlook by S&P Global Ratings
  • · S&P press release dated November 3, 2026; company disclosure dated November 4, 2026
  • · Filing also copied to Luxembourg Stock Exchange and Singapore Exchange, indicating listing of the notes on those venues
Tata Consultancy Services Limited Company Update mixed materiality 3/10

04-11-2026

TCS released its TCS Enterprise AI Study, a 25-country survey of 1,333 senior leaders, finding that 84% of executives rank productivity as AI's top source of value while only 10% allow AI agents to execute decisions without human approval across multiple functions. Security, risk and governance now rank as the leading factor shaping AI deployment, ahead of cost, speed and ease of deployment. The findings point to a gap between realized AI value and readiness to grant AI greater autonomy, with mixed signals on AI economics and sovereignty preparedness.

  • · Only 9% of executives report AI agents capable of securely orchestrating workflows across enterprise applications
  • · Only 7% of global respondents have organization-wide provider-switching continuity plans, suggesting sovereignty concerns advance faster than operational preparedness
  • · UK and Ireland stood out on operational resilience, with comparatively strong AI continuity planning and governance integration
  • · North America showed particular strength in enterprise AI foundations; Europe showed strong focus on AI sovereignty
  • · 46% report targeted deployment of open-source AI for selected use cases
  • · Study is available as a full report titled 'TCS Enterprise AI Study: Intelligence that is Real'
HCL Technologies Limited Market Update neutral materiality 2/10

04-11-2026

HCL Technologies intimated BSE and NSE that its executives will participate in three investor conferences between November 16 and 19, 2026: the JM Financial Annual India Conference (Mumbai), the 29th CITIC CLSA India Forum (Mumbai), and Morgan Stanley's Twenty-Fifth Annual Asia Pacific Summit (Singapore). The company also noted that one-on-one investor meetings may occur, while stating that no unpublished price sensitive information will be shared. The filing contains no financial results or quantitative performance data.

  • · Conference dates: November 16-18, 2026 (JM Financial and CITIC CLSA) and November 18-19, 2026 (Morgan Stanley)
  • · BSE Scrip Code 532281 and NSE Scrip Code HCLTECH

Get daily alerts with 9 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 20 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: BSE Sensex 30 Stocks Regulatory Filings

🇮🇳 More from India

View all →